Patrick B. Walter, Eric A. Macklin, John Porter, Patricia Evans, Janet L. Kwiatkowski, Ellis J. Neufeld, Thomas Coates, Patricia J. Giardina, Elliott Vichinsky, Nancy Olivieri, Daniele Alberti, Jaymes Holland, Paul Harmatz. Inflammation and oxidant-stress in β-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. haematol [Internet]. 2008May31 [cited 2024Nov.22];93(6):817-25. Available from: https://haematologica.org/article/view/4873